BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pitisuttithum P, Chan WK, Goh GBB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. World J Gastroenterol 2020; 26(19): 2416-2426 [PMID: 32476802 DOI: 10.3748/wjg.v26.i19.2416]
URL: https://www.wjgnet.com/2150-5330/full/v26/i19/2416.htm
Number Citing Articles
1
Liling Wu, Man Zhang, Haofei Hu, Qijun Wan. Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective studyLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01577-8
2
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, George Boon-Bee Goh, Wah-Kheong Chan. Nonalcoholic Fatty Liver DiseaseMedical Clinics of North America 2023; 107(3): 449 doi: 10.1016/j.mcna.2022.12.003
3
Liwei Ji, Xintian Cai, Yang Bai, Tao Li. Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from ChinaInternational Journal of General Medicine 2021; : 2909 doi: 10.2147/IJGM.S319759
4
Sebastian Lang, Philipp Wilhelm Sänger, Sandra Kocina, Christian von Loeffelholz. Hypoxia in A Patient with Anti-p200 Pemphigoid under Combined Dapsone and Pantoprazole TreatmentBiomedicines 2022; 10(11): 2837 doi: 10.3390/biomedicines10112837
5
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne. NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatmentDiabetes & Metabolism 2021; 47(2): 101215 doi: 10.1016/j.diabet.2020.101215
6
Xiaomin Hu, Ruilin Zhou, Hanyu Li, Xinyue Zhao, Yueshen Sun, Yue Fan, Shuyang Zhang. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular OutcomesFrontiers in Cardiovascular Medicine 2022; 8 doi: 10.3389/fcvm.2021.805812
7
Kamran Mehrabani-Zeinabad, Awat Feizi, Masoumeh Sadeghi, Hamidreza Roohafza, Mohammad Talaei, Nizal Sarrafzadegan. Cardiovascular disease incidence prediction by machine learning and statistical techniques: a 16-year cohort study from eastern Mediterranean regionBMC Medical Informatics and Decision Making 2023; 23(1) doi: 10.1186/s12911-023-02169-5
8
Aizatul Shafiqah Mohd Faizal, T. Malathi Thevarajah, Sook Mei Khor, Siow-Wee Chang. A review of risk prediction models in cardiovascular disease: conventional approach vs. artificial intelligent approachComputer Methods and Programs in Biomedicine 2021; 207: 106190 doi: 10.1016/j.cmpb.2021.106190
9
Panyavee Pitisuttithum, Sombat Treeprasertsuk. Nonalcoholic fatty liver disease (NAFLD) among older adultsPortal Hypertension & Cirrhosis 2022; 1(3): 184 doi: 10.1002/poh2.31